关于直肠神经内分泌新生体管理的最新情况
Aviva Frydman1, Raj Srirajaskanthan2,3
1Neuroendocrine Tumour Unit, King's College Hospital, London, UK.
Current treatment options in oncology
|October 30, 2024
概括
直肠神经内分泌瘤 (NENs) 需要仔细的分期和切除以治愈,根据瘤特征可选择内镜或手术. 晚期病例可能需要全身疗法.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 手术病理学手术病理学
背景情况:
- 直肠神经内分泌瘤 (NEN) 的发病率正在上升.
- 大多数直肠NEN都是低度,分化良好的瘤,预后良好.
- 尽管结果很好,但转移潜力需要治疗意图切除.
研究的目的:
- 为管理直肠NEN提供当前证据的最新审查.
- 引导选择适当的诊断和治疗策略.
- 为临床决策提供有关切除和全身疗法的信息.
主要方法:
- 关于直肠NEN的当前文献和回顾性研究的综述.
- 对影响内镜和手术切除之间的选择因素的分析.
- 对晚期或转移性直肠NEN的全身治疗选择的评估.
主要成果:
- 切除提供了唯一的治愈选择,并建议防止转移.
- 瘤特征 (大小,等级,入侵,节点/远程转移) 决定了切除技术.
- 系统性疗法包括索马托斯塔丁类似物,埃弗罗利斯,TKI,化疗和PRRT.
结论:
- 对直肠NEN的最佳管理取决于精确的分期和量身定制的切除策略.
- 鉴于这些瘤的罕见性和复杂性,多学科的方法至关重要.
- 需要继续进行研究,以完善直肠NEN的治疗方案.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
125
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
125
Peptic Ulcer Disease V: Surgical Management and Nursing Care
233
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
233
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149
Drugs for Treatment of Diarrhea-Predominant IBS
149
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
149
Irritable Bowel Syndrome III: Medical and Nursing Management
173
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
173


